Thermoresponsive Solid Dispersion to Enhance Dissolution Profile of Atorvastatin Calcium: An Industrially Sustainable Alternative to Conventional Approaches. [PDF]
Sherif AY, Ibrahim MA.
europepmc +1 more source
Atorvastatin, a widely prescribed 3-hydroxy-3-methyl-glutaryl-coenzyme A reductase inhibitor (HMG-CoA reductase inhibitor), is associated with various adverse effects, including many dermatologic manifestations.
Al-Moussally, Feras +5 more
core +1 more source
Structural basis for rosuvastatin-induced activation of skeletal muscle ryanodine receptor 1. [PDF]
Weninger G +8 more
europepmc +1 more source
Atorvastatin Mitigates Hypercholesterolemia-Induced Alterations in Cerebral Mitochondrial Dehydrogenases in Rats. [PDF]
Belczyk M +4 more
europepmc +1 more source
Pathophysiological modulations by Trimad, a polyherbal formulation, in a rat model of high-fat diet-induced obesity. [PDF]
Joshi AA +4 more
europepmc +1 more source
Overcoming Drug Loading and Dosage Volume Challenges of Adsorption-Solidified SNEDDS by pH-Modulation Strategy: Atorvastatin Calcium and Glibenclamide as Model Drugs. [PDF]
Sherif AY, Altamimi MA.
europepmc +1 more source
Liver enzyme elevations during statin-ezetimibe therapy in <i>ABCG2</i> c.421C>A variant carriers: a case series and narrative review. [PDF]
Šimičević L +6 more
europepmc +1 more source
Hybutimibe, an innovative cholesterol absorption inhibitor for lipid-lowering therapy: current evidence and future perspectives. [PDF]
Li S, Liu HH, Li JJ.
europepmc +1 more source
Comparative Effects of Different Statin Regimens on Postoperative Outcomes in Isolated Coronary Artery Bypass Grafting: A Propensity Score-Matched Analysis. [PDF]
Beyazal OF +7 more
europepmc +1 more source
[<sup>18</sup>F]FDG PET/CT as an endpoint marker in drug interventional studies in atherosclerosis - a structured review. [PDF]
Gijsen CEW +4 more
europepmc +1 more source

